 Mutant APC molecules that lack anticoagulant activity and the associated bleedingcomplications are expected to improve patient survival Bolus dosing of the drug offers more simplified use Exclusively licensed in 2010
[更多]
Optical probesOptoelectronic circuitsOptical interconnectsNanoscale detectorsExascale computing
[更多]
| |< <- | [3565] [3566] [3567] [3568] [3569] [3570] [3571] [3572] [3573] [3574] [3575] | -> >| |
